Tony Richardson, Chief Executive Officer of Venn Life Sciences explains their leading edge in the industry and looking forward through 2015 looking to expand further in central and eastern Europe.
Venn Life Scienes are a European CRO with over 24 years’ experience in the management & resourcing of clinical trials. Therapeutically focused, they have worked with pharmaceutical, biotech and medical device companies for a quarter of a century, navigating efficiently the often difficult European clinical trial landscape. Their close relationships with hospitals, investigators, regulators and key opinion leaders coupled with expertise as a team make planning and running trials easier for all.
Tony Richardson is CEO of Venn Life Sciences. He has over 15 years experience in the Life Science arena. Mr. Richardson has held key leadership positions in a number of Medical Technology companies and has accumulated considerable transaction experience including IPO, financings and M&A.
For more information about Venn Life Sciences visit: vennlifesciences.com
There aren't any comments yet.